CRISPR/Cas9 technology generated a C to T change at position 1411 (c.1411C>T) resulting in a stop codon at arginine 471 (p.R471*) in exon 21. This is a mutation described in a patient with Alport Syndrome. qPCR indicates decreased mRNA levels in the renal cortex.